Valeant grants Actavis license to market generic Acanya Gel beginning July 1, 2018
DUBLIN — Actavis on Monday announced that it has entered into an agreement with Valeant Pharmaceuticals International to settle all outstanding patent litigation related to Actavis’ generic version of Acanya (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/2.5%. Acanya Gel is a lincosamide antibiotic and benzoyl peroxide indicated for the topical treatment of acne vulgaris.
Under the terms of the agreement, Valeant will grant Actavis a license to market its generic Acanya Gel beginning July 1, 2018 or earlier under certain circumstances. Other details of the settlement were not disclosed.
Launch of Actavis’ product is contingent upon Actavis receiving final approval from the Food and Drug Administration on its abbreviated new drug application for generic Acanya Gel. Based on available information, Actavis believes it may be a "first applicant" to file an ANDA for the generic version of Acanya Gel and, should its ANDA be approved, may be entitled to 180 days of generic market exclusivity.
For the 12 months ended Feb. 28, Acanya had total U.S. sales of approximately $121 million, according to IMS Health data.
Alaska legislature passes telemedicine bill
JUNEAU, Alaska — The 28th Alaska Legislature in late April passed legislation that will allow patients to obtain over-the-phone or online consultations where physicians can diagnose and, if necessary, provide a prescription.
“Nowadays, much of our life is conducted online or over the phone,” said Rep. Lynne Gattis, R-Wasilla. “In this age where we can do almost everything with a smartphone, it should not be necessary to drive to the doctor’s office to have a physical consultation for many common ailments.”
This bill is as much about access as it is convenience. “With 20% of our population living in rural areas, it is imperative that access to routine medical care be as quick and economical as possible,” Gattis said.
House Bill 281 does not allow physicians to prescribe controlled substances without an examination unless another licensed healthcare provider is present with the patient.
The Alaska Native Tribal Health Consortium, Veterans Affairs hospital and the military already operate telemedicine in Alaska by using a federal exemption. “This bill mimics the system already in place for some Alaskans and makes it available to everyone,” Gattis said. “Anyone needing medical care would be able to use the affordable and accessible system.”
HB 281 now goes to the Governor for signature.
Coram CVS/specialty infusion services opens new branch in El Paso, Texas
WOONSOCKET, R.I. — Coram CVS/specialty infusion services has announced the opening of a new branch pharmacy in El Paso, Texas, that will serve the Big Bend, Panhandle and Permian Basin areas of Texas, as well as southern New Mexico.
The new facility, which is larger than the previous branch location, offers a number of services, including:
- Ambulatory infusion suite, which provides an alternative to a hospital setting where patients can receive IV infusion of specialty drugs in a safe, monitored environment;
- Infusion therapies, including anti-infective services, parenteral nutrition (PN) and enteral nutrition (tube feeding), cardiac/inotropic therapies, immunoglobulins (IVIg and SCIg), Alpha-1 therapies and pain and palliative care services;
- Compounding "clean room," which is compliant with USP 797 pharmaceutical compounding standards;
- Peripherally inserted central catheter (PICC) line placement using state-of-the-art technology. This new service enables infusion therapy to begin immediately, without the need for an x-ray confirmation or hospitalization;
- Individual patient counseling and education;
- Nursing services; and
- Nursing language services available in English and Spanish.
"As the only national infusion services company in the area, Coram is pleased to build upon our long-standing investment in the El Paso community and the surrounding areas with the opening of this branch," said Rob Allen, president, Coram CVS/specialty infusion services. "We know that infusion care provided in the home or at an alternate site infusion suite can help promote better health and an improved quality of life for patients with complex infusion needs."
In January, CVS Caremark acquired Coram, the specialty infusion services and enteral nutrition business unit of Apria Healthcare Group. Coram is one of the nation’s largest providers of comprehensive infusion services, caring for approximately 165,000 patients annually.